Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

NCT05607420 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Non-Hodgkin Lymphoma (B-NHL)

Interventions

BIOLOGICAL: UCART20x22
BIOLOGICAL: CLLS52

Sponsor

Cellectis S.A.